Literature DB >> 12351683

Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity.

Per Hammarström1, Xin Jiang, Amy R Hurshman, Evan T Powers, Jeffery W Kelly.   

Abstract

Several misfolding diseases commence when a secreted folded protein encounters a partially denaturing microenvironment, enabling its self assembly into amyloid. Although amyloidosis is modulated by numerous environmental and genetic factors, single point mutations within the amyloidogenic protein can dramatically influence disease phenotype. Mutations that destabilize the native state predispose an individual to disease; however, thermodynamic stability alone does not reliably predict disease severity. Here we show that the rate of transthyretin (TTR) tetramer dissociation required for amyloid formation is strongly influenced by mutation (V30M, L55P, T119M, V122I), with rapid rates exacerbating and slow rates reducing amyloidogenicity. Although these rates are difficult to predict a priori, they notably influence disease penetrance and age of onset. L55P TTR exhibits severe pathology because the tetramer both dissociates quickly and is highly destabilized. Even though V30M and L55P TTR are similarly destabilized, the V30M disease phenotype is milder because V30M dissociates more slowly, even slower than wild type (WT). Although WT and V122I TTR have nearly equivalent tetramer stabilities, V122I cardiomyopathy, unlike WT cardiomyopathy, has nearly complete penetrance-presumably because of its 2-fold increase in dissociation rate. We show that the T119M homotetramer exhibits kinetic stabilization and therefore dissociates exceedingly slowly, likely explaining how it functions to protect V30MT119M compound heterozygotes from disease. An understanding of how mutations influence both the kinetics and thermodynamics of misfolding allows us to rationalize the phenotypic diversity of amyloid diseases, especially when considered in concert with other genetic and environmental data.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351683      PMCID: PMC139904          DOI: 10.1073/pnas.202495199

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  A protein-folding reaction under kinetic control.

Authors:  D Baker; J L Sohl; D A Agard
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

Review 2.  Genetic aspects of amyloidosis.

Authors:  D R Jacobson; J N Buxbaum
Journal:  Adv Hum Genet       Date:  1991

Review 3.  Alternative conformations of amyloidogenic proteins govern their behavior.

Authors:  J W Kelly
Journal:  Curr Opin Struct Biol       Date:  1996-02       Impact factor: 6.809

4.  Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.

Authors:  D R Jacobson; R D Pastore; R Yaghoubian; I Kane; G Gallo; F S Buck; J N Buxbaum
Journal:  N Engl J Med       Date:  1997-02-13       Impact factor: 91.245

Review 5.  Familial amyloid polyneuropathy: new developments in genetics and treatment.

Authors:  T Coelho
Journal:  Curr Opin Neurol       Date:  1996-10       Impact factor: 5.710

6.  Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease.

Authors:  S L McCutchen; Z Lai; G J Miroy; J W Kelly; W Colón
Journal:  Biochemistry       Date:  1995-10-17       Impact factor: 3.162

7.  A role for destabilizing amino acid replacements in light-chain amyloidosis.

Authors:  M R Hurle; L R Helms; L Li; W Chan; R Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

Review 8.  Transthyretin mutations in health and disease.

Authors:  M J Saraiva
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

9.  The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.

Authors:  Z Lai; W Colón; J W Kelly
Journal:  Biochemistry       Date:  1996-05-21       Impact factor: 3.162

10.  Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate.

Authors:  G Holmgren; P M Costa; C Andersson; K Asplund; L Steen; L Beckman; P O Nylander; A Teixeira; M J Saraiva; P P Costa
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

View more
  108 in total

1.  Sequence determinants of amyloid fibril formation.

Authors:  Manuela López de la Paz; Luis Serrano
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

2.  Oligomerization of amyloid Abeta16-22 peptides using hydrogen bonds and hydrophobicity forces.

Authors:  Giorgio Favrin; Anders Irbäck; Sandipan Mohanty
Journal:  Biophys J       Date:  2004-09-17       Impact factor: 4.033

Review 3.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

4.  Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion.

Authors:  Steve Bourgault; James P Solomon; Natàlia Reixach; Jeffery W Kelly
Journal:  Biochemistry       Date:  2011-01-24       Impact factor: 3.162

5.  Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.

Authors:  Christine E Bulawa; Stephen Connelly; Michael Devit; Lan Wang; Charlotte Weigel; James A Fleming; Jeff Packman; Evan T Powers; R Luke Wiseman; Theodore R Foss; Ian A Wilson; Jeffery W Kelly; Richard Labaudinière
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

6.  Amyloid formation of a protein in the absence of initial unfolding and destabilization of the native state.

Authors:  Gemma Soldi; Francesco Bemporad; Silvia Torrassa; Annalisa Relini; Matteo Ramazzotti; Niccolò Taddei; Fabrizio Chiti
Journal:  Biophys J       Date:  2005-09-16       Impact factor: 4.033

7.  Simulation of pH-dependent edge strand rearrangement in human beta-2 microglobulin.

Authors:  Sheldon Park; Jeffery G Saven
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

8.  Stress-independent activation of XBP1s and/or ATF6 reveals three functionally diverse ER proteostasis environments.

Authors:  Matthew D Shoulders; Lisa M Ryno; Joseph C Genereux; James J Moresco; Patricia G Tu; Chunlei Wu; John R Yates; Andrew I Su; Jeffery W Kelly; R Luke Wiseman
Journal:  Cell Rep       Date:  2013-04-11       Impact factor: 9.423

9.  Amyloidogenic potential of transthyretin variants: insights from structural and computational analyses.

Authors:  Laura Cendron; Antonio Trovato; Flavio Seno; Claudia Folli; Beatrice Alfieri; Giuseppe Zanotti; Rodolfo Berni
Journal:  J Biol Chem       Date:  2009-07-14       Impact factor: 5.157

10.  Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial.

Authors:  Teresa Coelho; Luis F Maia; Ana Martins da Silva; Marcia Waddington Cruz; Violaine Planté-Bordeneuve; Pierre Lozeron; Ole B Suhr; Josep M Campistol; Isabel Maria Conceição; Hartmut H-J Schmidt; Pedro Trigo; Jeffery W Kelly; Richard Labaudinière; Jason Chan; Jeff Packman; Amy Wilson; Donna R Grogan
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.